Use of
The present invention provides the use of Lactobacillus paracasei , for maintaining or increasing the intestinal microbiota diversity in a subject having dysbiosis.
1. A method to treat an infection caused by a vancomycin-resistant Enterococcus faecalis in the intestinal microbiota of a subject having a dysbiosis caused by or subsequent to antibiotic treatment of said subject, comprising administering Lactobacillus paracasei subspecies paracasei strain CNCM I-3689 to said subject.
2. The method according to claim 1 , wherein said Enterococcus faecalis are further resistant to antibiotics selected from penicillins, cephalosporins, fluoroquinolones, aminoglycosides, and glycopeptides.
3. The method according to claim 1 , wherein said Enterococcus faecalis are part of a High-Risk Enterococcal Clonal Complex.
4. The method according to claim 1 , wherein said Lactobacillus paracasei is in an orally administrable composition.
5. The method according to claim 4 , wherein said composition is a fermented dairy product.
6. The method according to claim 1 , wherein said dysbiosis is characterized by an increase in Firmicutes.